Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.08) by 87.95 percent. This is a 83.33 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $4.565 million which missed the analyst consensus estimate of $8.286 million by 44.90 percent. This is a 283.61 percent increase over sales of $1.190 million the same period last year.